Literature DB >> 7202438

Progressive supranuclear palsy: pneumoencephalography, electronystagmography and treatment with methysergide.

G W Paulson, H W Lowery, G C Taylor.   

Abstract

15 patients with progressive supranuclear palsy (PSP) are presented with discussion of the value of pneumoencephalography (PEG) and electronystagmography (ENG) in confirming the diagnosis. PEG was performed in 6 patients, and revealed atrophy in the area of the pons and colliculi. ENG, which also was performed in 6 patients, 4 of whom had PEG, confirmed the defects in extraocular movement. Methysergide, which has been suggested as therapy for PSP, was utilized in 6 patients with no evidence of significant improvement.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7202438     DOI: 10.1159/000115198

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  3 in total

1.  Treatment of progressive supranuclear palsy with methysergide. A clinical study.

Authors:  G Di Trapani; P Stampatore; A La Cara; A Azzoni; M L Vaccario
Journal:  Ital J Neurol Sci       Date:  1991-04

Review 2.  Progressive supranuclear palsy: clinical features, pathophysiology and management.

Authors:  A Rajput; A H Rajput
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 3.  A Review of Treatment Options for Progressive Supranuclear Palsy.

Authors:  Maria Stamelou; Günter Höglinger
Journal:  CNS Drugs       Date:  2016-07       Impact factor: 5.749

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.